United States Environmental Protection Agency
Integrated Risk Information System Logo


Dibenzofuran
CASRN 132-64-9

Contents


0429
Dibenzofuran; CASRN 132-64-9  


Health assessment information on a chemical substance is included in IRIS only 
after a comprehensive review of chronic toxicity data by U.S. EPA health 
scientists from several Program Offices and the Office of Research and 
Development.  The summaries presented in Sections I and II represent a 
consensus reached in the review process.  Background information and 
explanations of the methods used to derive the values given in IRIS are 
provided in the Background Documents. 


STATUS OF DATA FOR  Dibenzofuran

File On-Line 10/01/1990

Category (section)                           Status      Last Revised
-----------------------------------------    --------    ------------

Oral RfD Assessment (I.A.)                   no data     

Inhalation RfC Assessment (I.B.)             no data       05/01/1992

Carcinogenicity Assessment (II.)             on-line       10/01/1990



_I. CHRONIC HEALTH HAZARD ASSESSMENTS FOR NONCARCINOGENIC EFFECTS __I.A. REFERENCE DOSE FOR CHRONIC ORAL EXPOSURE (RfD) Substance Name -- Dibenzofuran CASRN -- 132-64-9 Not available at this time.
__I.B. REFERENCE CONCENTRATION FOR CHRONIC INHALATION EXPOSURE (RfC) Substance Name -- Dibenzofuran CASRN -- 132-64-9 Not available at this time.
_II. CARCINOGENICITY ASSESSMENT FOR LIFETIME EXPOSURE Substance Name -- Dibenzofuran CASRN -- 132-64-9 Last Revised -- 10/01/1990 Section II provides information on three aspects of the carcinogenic assessment for the substance in question; the weight-of-evidence judgment of the likelihood that the substance is a human carcinogen, and quantitative estimates of risk from oral exposure and from inhalation exposure. The quantitative risk estimates are presented in three ways. The slope factor is the result of application of a low-dose extrapolation procedure and is presented as the risk per (mg/kg)/day. The unit risk is the quantitative estimate in terms of either risk per ug/L drinking water or risk per ug/cu.m air breathed. The third form in which risk is presented is a drinking water or air concentration providing cancer risks of 1 in 10,000, 1 in 100,000 or 1 in 1,000,000. The rationale and methods used to develop the carcinogenicity information in IRIS are described in The Risk Assessment Guidelines of 1986 (EPA/600/8-87/045) and in the IRIS Background Document. IRIS summaries developed since the publication of EPA's more recent Proposed Guidelines for Carcinogen Risk Assessment also utilize those Guidelines where indicated (Federal Register 61(79):17960-18011, April 23, 1996). Users are referred to Section I of this IRIS file for information on long-term toxic effects other than carcinogenicity. __II.A. EVIDENCE FOR CLASSIFICATION AS TO HUMAN CARCINOGENICITY ___II.A.1. WEIGHT-OF-EVIDENCE CLASSIFICATION Classification -- D; not classifiable as to human carcinogenicity Basis -- Based on no human data and no animal data for dibenzofuran alone. ___II.A.2. HUMAN CARCINOGENICITY DATA None. There are no data on the possible carcinogenicity of dibenzofuran alone in humans. Studies have evaluated exposure to a mixture of polychlorinated biphenyls (PCBs), polychlorinated dibenzofurans (PCDFs) and polychlorinated quinones (PCQs) by consumption of contaminated rice oil (Yusho incident) (reviewed in U.S. EPA, 1986, 1987). However, these studies have limited value because they do not assess dibenzofuran or correlate exposure with cancer risk. Additionally, because of the multiple exposures, the extent to which the various components contributed to the increase in cancer mortality cannot be determined. ___II.A.3. ANIMAL CARCINOGENICITY DATA None. No animal carcinogenicity data on dibenzofuran are currently available. U.S. EPA (1986) noted that the biological activity of PCDFs varies greatly, so that risk assessment of dibenzofuran by analogy to any of these more widely studied compounds would not be recommended. ___II.A.4. SUPPORTING DATA FOR CARCINOGENICITY Dibenzofuran is not mutagenic with or without metabolic activation in several strains of Salmonella typhimurium assay (Schoeny, 1982). In a comparison of Toxic Equivalency Factor (TEF) values for chlorinated dibenzofurans, mono-, di- and tri-chlorinated dibenzofuran had TEF values of O (U.S. EPA, 1989). Based on these results and the fact that toxicity of polychlorinated dibenzofurans (PCDF) depends on the number of chlorine SUBSTituents and their position (U.S. EPA, 1986), the TEF for dibenzofuran, with no chlorine SUBSTituents, is set equal to O.
__II.B. QUANTITATIVE ESTIMATE OF CARCINOGENIC RISK FROM ORAL EXPOSURE None.
__II.C. QUANTITATIVE ESTIMATE OF CARCINOGENIC RISK FROM INHALATION EXPOSURE None.
__II.D. EPA DOCUMENTATION, REVIEW, AND CONTACTS (CARCINOGENICITY ASSESSMENT) ___II.D.1. EPA DOCUMENTATION Source Document -- U.S. EPA, 1986, 1987, 1989 The 1986 Health Assessment for Polychlorinated Dibenzofurans is an external draft for review purposes only and does not constitute Agency policy. The 1987 Health Effects Assessment Document for Dibenzofuran has been reviewed in accordance with the U.S. Environmental Protection Agency's peer and administrative review policies and has been approved for publication. ___II.D.2. REVIEW (CARCINOGENICITY ASSESSMENT) Agency Work Group Review -- 10/05/1989 Verification Date -- 10/05/1989 ___II.D.3. U.S. EPA CONTACTS (CARCINOGENICITY ASSESSMENT) Please contact the Risk Information Hotline for all questions concerning this assessment or IRIS, in general, at (513)569-7254 (phone), (513)569-7159 (FAX) or RIH.IRIS@EPAMAIL.EPA.GOV (internet address).
_VI. BIBLIOGRAPHY Substance Name -- Dibenzofuran CASRN -- 132-64-9 Last Revised -- 10/01/1990 __VI.A. ORAL RfD REFERENCES None
__VI.B. INHALATION RfD REFERENCES None
__VI.C. CARCINOGENICITY ASSESSMENT REFERENCES Schoeny, R. 1982. Mutagenicity testing of chlorinated biphenyls and chlorinated dibenzofurans. Mutat. Res. 101: 45-56. U.S. EPA. 1986. Health Assessment Document for Polychlorinated Dibenzofurans. Prepared by the Office of Health and Environmental Assessment, Environmental Criteria and Assessment Office, Cincinnati, OH for the Office of Air Quality Planning and Standards, Research Triangle Park, NC. EPA 600/8- 86/018A. NTIS PB86-221256/AS. U.S. EPA. 1987. Health Effects Assessment for Dibenzofuran. Prepared by the Office of Health and Environmental Assessment, Environmental Criteria and Assessment Office, Cincinnati, OH for the Office of Emergency and Remedial Response, Washington, DC. ECAO-CIN-H088. U.S. EPA. 1989. Interim Procedures for Estimating Risks Associated with Exposures to Mixtures of Chlorinated Dibenzo-p-Dioxins and -Dibenzofurans (CDDs and CDFs) and 1989 Update. Risk Assessment Forum, Washington, DC. EPA/625/3-89/016.
_VII. REVISION HISTORY Substance Name -- Dibenzofuran CASRN -- 132-64-9 -------- -------- -------------------------------------------------------- Date Section Description -------- -------- -------------------------------------------------------- 10/01/1990 II. Carcinogen assessment on-line 10/01/1990 VI. Bibliography on-line 01/01/1992 IV. Regulatory Action section on-line 05/01/1992 I.B. Inhalation RfC now under review
VIII. SYNONYMS Substance Name -- Dibenzofuran CASRN -- 132-64-9 Last Revised -- 10/01/1990 132-64-9 (1,1'-BIPHENYL)-2,2'-DIYL OXIDE 2,2'-BIPHENYLENE OXIDE 2,2'-BIPHENYLYLENE OXIDE DIBENZOFURAN DIBENZO(B,D)FURAN DIPHENYLENE OXIDE HSDB 2163 NSC 1245



IRIS Home Page Substance File List
Comments on the IRIS web site Search the IRIS database National Center for Environmental Assessment Office of Research and Development's Home Page EPA's Home Page


Last updated: 5 May 1998
URL: http://www.epa.gov/iris/SUBST/0429.HTM